As of 2024-12-12, the Relative Valuation of 10X Genomics Inc (TXG) is (49.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.08 USD, the upside of 10X Genomics Inc based on Relative Valuation is -404.8%.
The range of the Relative Valuation is (45.88) - (50.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.4x - 33.6x | 33.3x |
| Forward P/E multiples | 30.4x - 33.2x | 31.7x |
| Fair Price | (45.88) - (50.10) | (49.01) |
| Upside | -385.3% - -411.6% | -404.8% |
| Date | P/E |
| 2024-12-11 | -10.66 |
| 2024-12-10 | -10.71 |
| 2024-12-09 | -10.71 |
| 2024-12-06 | -10.52 |
| 2024-12-05 | -10.10 |
| 2024-12-04 | -10.60 |
| 2024-12-03 | -10.49 |
| 2024-12-02 | -10.92 |
| 2024-11-29 | -10.54 |
| 2024-11-27 | -10.26 |
| 2024-11-26 | -9.95 |
| 2024-11-25 | -10.15 |
| 2024-11-22 | -9.49 |
| 2024-11-21 | -8.81 |
| 2024-11-20 | -8.83 |
| 2024-11-19 | -9.00 |
| 2024-11-18 | -8.74 |
| 2024-11-15 | -8.85 |
| 2024-11-14 | -9.36 |
| 2024-11-13 | -9.89 |
| 2024-11-12 | -10.40 |
| 2024-11-11 | -10.54 |
| 2024-11-08 | -10.37 |
| 2024-11-07 | -10.72 |
| 2024-11-06 | -11.01 |
| 2024-11-05 | -11.50 |
| 2024-11-04 | -11.13 |
| 2024-11-01 | -10.83 |
| 2024-10-31 | -10.63 |
| 2024-10-30 | -10.93 |
| 2024-10-29 | -10.47 |
| 2024-10-28 | -10.52 |
| 2024-10-25 | -10.27 |
| 2024-10-24 | -10.26 |
| 2024-10-23 | -10.01 |
| 2024-10-22 | -10.04 |
| 2024-10-21 | -10.19 |
| 2024-10-18 | -10.24 |
| 2024-10-17 | -9.85 |
| 2024-10-16 | -10.44 |
| 2024-10-15 | -10.55 |
| 2024-10-14 | -10.79 |
| 2024-10-11 | -10.78 |
| 2024-10-10 | -10.39 |
| 2024-10-09 | -13.80 |
| 2024-10-08 | -13.33 |
| 2024-10-07 | -13.15 |
| 2024-10-04 | -13.28 |
| 2024-10-03 | -13.00 |
| 2024-10-02 | -13.35 |